News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
Talecris Biotherapeutics CEO and Chairman Larry Stern to Ring the NASDAQ Stock Market Opening Bell
October 1, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ADVISORY, Oct. 1, 2009 (GLOBE NEWSWIRE) -- What: Larry Stern, Chairman and Chief Executive Officer of Talecris Biotherapeutics (TLCR), will preside over the NASDAQ opening bell.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Obesity
EASD 2025: Orforglipron in Focus, the Case for Cardiovascular Benefits, More
September 15, 2025
·
6 min read
·
Tristan Manalac
Government
Second MAHA Report Emphasizes Chronic Disease, Tilts at Vaccine Reform
September 9, 2025
·
3 min read
·
Heather McKenzie
Government
Senate Hearing Devolves Into Theater as Kennedy Accused of Breaking Vaccine Promises
September 5, 2025
·
4 min read
·
Dan Samorodnitsky
ALS
New Wave of ALS Therapies Signals Renaissance After Incremental Regression
September 2, 2025
·
6 min read
·
Heather McKenzie
